Skip to content
OpenCapital
Get started

Denali Therapeutics Inc. DNLI Milestone Triggered — Total collaboration revenue

Other product segments

Milestone Payment
$2.5M0.0%
Option Fee Payment
$2.5M+100%

Similar metrics at other companies

Incyte logo
INCYMilestone and contract revenues — Total revenues
$17M—
Dianthus Therapeutics logo
DNTHMilestone — Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer
$7M+600%
Exelixis logo
EXELCollaboration — Total revenues
$55.84M+32.4%
Arcus Biosciences logo
RCUSOther collaboration — Total revenues
$5M-37.5%
Exelixis logo
EXELCollaboration services revenues — Revenue from contract with customer, commercial sales milestone
$2.4M—
Crinetics Pharmaceuticals logo
CRNXCollaboration and license revenue — Total Revenue
$428K+18.6%

Other financials

Income statement

See full
Revenue-—
Operating income-$137.4M+5.6%
Net income-$128.4M+3.4%
EPS (diluted)-$0.69+11.5%

Balance sheet

See full
Cash & equivalents$390.7M+551%
Total debt$40.0M-22.3%
Total equity$926.1M-17.5%
Total assets$1.3B-0.4%

Cash flow

See full
Operating cash flow-$131.2M+0.2%
CapEx$2.5M-51.4%
Free cash flow-$133.7M+2.1%

Valuation

See full
Market cap$3.93B+54.2%

Profitability

See full
Operating margin-37,938%-37,986pp
Net margin-33,121.9%-33,159pp
FCF margin-31,736.3%-31,830pp

Returns & leverage

See full
Return on equity-49.6%+34.2pp
Debt / equity0×0.0×
Current ratio9.3×-0.3×

Where this comes from

Reported directly by Denali Therapeutics Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue?
Denali Therapeutics Inc. (DNLI) reported milestone triggered — total collaboration revenue of $25M in Q4 2026.
How has Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue changed year-over-year?
Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue decreased by 0.0% year-over-year, from $25M to $25M.
What is the long-term trend for Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue?
Over 3 years (2022 to 2026), Denali Therapeutics Inc.'s milestone triggered — total collaboration revenue has grown at a 15.4% compound annual growth rate (CAGR), from $65M to $100M.
What does milestone triggered — total collaboration revenue mean?
Represents the aggregate revenue recognized from collaborative research and development agreements within a specific business segment. This metric captures the financial value derived from achieving contractually defined milestones or performance obligations in partnership with other entities. It serves as a key indicator of the commercial success and progress of the company's joint development programs.